# Association Between Chronic Kidney Disease Stage and Circulating FGF23 Cleavage Intensity in Patients With Chronic Kidney Disease

> **NCT07676526** · NA · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 80 (estimated)

## Conditions studied

- CKD - Chronic Kidney Disease

## Interventions

- **OTHER:** Blood sampling and biomarker assessment

## Key facts

- **NCT ID:** NCT07676526
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07676526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07676526, "Association Between Chronic Kidney Disease Stage and Circulating FGF23 Cleavage Intensity in Patients With Chronic Kidney Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07676526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*